Myelin in Alzheimer’s disease: culprit or bystander?
Abstract Alzheimer’s disease (AD) is a neurodegenerative disorder with neuronal and synaptic losses due to the accumulation of toxic amyloid β (Αβ) peptide oligomers, plaques, and tangles containing tau (tubulin-associated unit) protein. While familial AD is caused by specific mutations, the sporadi...
Main Authors: | Michel Maitre, Hélène Jeltsch-David, Nwife Getrude Okechukwu, Christian Klein, Christine Patte-Mensah, Ayikoe-Guy Mensah-Nyagan |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-03-01
|
Series: | Acta Neuropathologica Communications |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40478-023-01554-5 |
Similar Items
-
Myelin organoids for the study of Alzheimer's disease
by: Jonas Cerneckis, et al.
Published: (2023-10-01) -
Myelin repair in Alzheimer’s disease: a review of biological pathways and potential therapeutics
by: Lauren Rose Hirschfeld, et al.
Published: (2022-10-01) -
5-HIAA induces neprilysin to ameliorate pathophysiology and symptoms in a mouse model for Alzheimer’s disease
by: Christian Klein, et al.
Published: (2018-12-01) -
Unraveling Myelin Plasticity
by: Giulia Bonetto, et al.
Published: (2020-06-01) -
Clemastine Ameliorates Myelin Deficits via Preventing Senescence of Oligodendrocytes Precursor Cells in Alzheimer’s Disease Model Mouse
by: Yuan-Yuan Xie, et al.
Published: (2021-10-01)